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Abstract
HIV-1 Nef modulates disease progression through interactions with over 30 host proteins. Individual chains fold into
membrane-interacting N-terminal and C-terminal core (Nefcore) domains respectively. Nef exists as small oligomers near
membranes and associates into higher oligomers such as tetramers or hexadecamers in the cytoplasm. Earlier structures of
the Nefcore in apo and complexed forms with the Fyn-kinase SH3 domain revealed dimeric association details and the role of
the conserved PXXP recognition motif (residues 72–78) of Nef in SH3-domain interactions. The crystal structure of the
tetrameric Nef reported here corresponds to the elusive cytoplasmic stage. Comparative analyses show that subunits of
Nefcore dimers (open conformation) swing out with a relative displacement of ,22 A ˚ and rotation of ,174u to form the
‘closed’ tetrameric structure. The changes to the association are around Asp125, a conserved residue important for viral
replication and the important XR motif (residues 107–108). The tetramer associates through C4 symmetry instead of the 222
symmetry expected when two dimers associate together. This novel dimer-tetramer transition agrees with earlier solution
studies including small angle X-ray scattering, analytical ultracentrifugation, dynamic laser light scattering and our
glutaraldehyde cross-linking experiments. Comparisons with the Nefcore—Fyn-SH3 domain complexes reveal that the PXXP
motif that interacts with the SH3-domain in the dimeric form is sterically occluded in the tetramer. However the 151–180
loop that is distal to the PXXP motif and contains several protein interaction motifs remains accessible. The results suggest
how changes to the oligomeric state of Nef can help it distinguish between protein partners.
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Introduction
HIV-1 Nef is an important accessory protein that is attributed
with multiple distinct functions such as immune evasion [1,2],
virion infectivity [3,4] and support for viral replication [5,6] and
survival. These functions are regulated through the interactions of
Nef with more than 30 different partner proteins in the membrane
anchored and cytoplasmic states respectively [7,8], It is puzzling as
to how this small ,27 kDa protein can control multiple important
functions. Vicinal to membranes, it exists as smaller oligomers
such as a dimer or a trimer, as seen in the core domain (Nefcore)
complexes with the SH3 domain of Fyn Kinase (FynSH3) [9–11].
On the other hand small angle X-ray scattering, dynamic light
scattering and analytical centrifugation studies show that the
cytoplasmic form exists as a tetramer or higher oligomers that
result when multiple tetramers associate together [12]. Further, a
4-fold symmetry was detected in the higher order Nef oligomers in
the solution studies. The latter has been postulated to be the ‘closed’
form where a subset of its numerous interactions with partner
proteins should be differently modulated [8]. Nef is modified co-
translationally through myristoylation at the N-terminus. A
population of the myristoylated form, as supported by affinity
experiments, exists in the cytoplasm where the N-terminal
myristoylated segment is suggestedly sequestered in the hydro-
phobic pockets between helices aA and aB of the C-terminal
domain [12,13].
Each Nef chain folds into two domains [14,15]. NMR studies
involving the N-terminal membrane interacting domain demonstrate
that it is highly flexible and loosely structured [16]. The C-terminal
core-domain functions as the oligomerization and protein interaction
domain. It contains the PXXP motif (Residues 72–78) that recognizes
SH3domains of partner proteins and other interaction motifs at a 30-
residue loop (Residues 149–178) distal to the PXXP motif [17]. Two
groups have reported structures of the Nefcore—FynSH3 complexes
[9,10]. The domain itself exists as a dimer in the apo and complexed
states and represents the ‘open’ form of the protein. The 30-residue
loop mentioned above is disordered in the complexes. This loop
contains distinct motifs suchas the di-Leu and EE motifs as also acidic
residue clusters that interact with different sets of host/accessory
proteins [8,18]. Thus motifs at different regions of the core domain
are involved in interactions with distinct subsets of protein partners
for enforcing its multiple functions.
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as also of the elusive ‘closed’ oligomeric form has not been reported
so far. This has led to a gap in understanding, in molecular terms,
as to how Nef modulates its interactions with partner proteins. We
report the crystallization of the full-length HIV-1 Nef after
experimentation with naturally occurring Nef variants from
patient samples and were successful with one such sample. This
Nef variant was earlier shown by our groups to exhibit
pathogenicity in a C. elegans model [19]. The protein adopts the
elusive closed tetrameric association in the structure. The transition
from a dimer to a tetramer involves large changes to the dimeric
association to form a tetramer with 4-fold symmetry. The
molecular details of the dimer-tetramer transitions help explain
how the protein can distinguish between different sets of protein
partners when it is in the membrane-associated and cytoplasmic
stages respectively. To our knowledge this is the first example
where a functional dimer-tetramer transition deviates from the
expected 222 symmetry to 4-fold symmetry. These large changes
to the intersubunit spatial disposition involve Asp125, a highly
conserved residue known to be important for viral replication and
the conserved XR motif (where X is Lys or Arg) [20,21] at the
intersubunit interface. In the earlier Nefcore—FynSH3 complexes
[9,10] the interaction of the conserved Asp was with the first
residue of the motif presumably leading to the observed dimeric
association, while in the present structure the interaction of the
Asp shifts to the second Arg residue of the motif leading to the
novel dimer-tetramer transition.
Results & Discussion
Crystallization and structure description
We attempted crystallization of the full-length HIV-1 Nef
(RP14) with several cloned samples derived from patients and were
successful with the sample with sequence as deposited in the
GenBank with accession number: GQ184340. This latter Nef
variant (RP14) was also shown to be pathogenic in a C. elegans
model [19]. Weak X-ray diffraction and crystal reproducibility
necessitated extensive screening of the crystals before data
collection. A comparison of the RP14 sequence with the NL4-3
strain used in the structure of the earlier reported core-domain of
HIV-1 Nef is in (Figure 1). The main difference is the absence of
the CAWLEAQ motif (residues 55–61) in the RP14 variant
compared to the earlier NL4-3 strain and insertion of 9 amino
acids after Arg20. These differences probably contribute to the
successful crystallization of the present construct compared to the
earlier efforts of other groups involving other Nef variants. In fact
our own crystallization attempts with full-length Nef variants that
contain the CAWLEAQ motif were not successful.
The asymmetric unit contains two protein chains that associate
through symmetry to form a tetramer. Three lines of arguments
suggest conclusively that the observed tetramer is not an artifact:
firstly, earlier solution and in vivo studies [22] demonstrated that
mutations to the corresponding Arg107 & 108 residues and Asp
125 residues in their construct severely impacted any oligomer-
ization. Secondly, small-angle X-ray scattering experiments [12]
clearly demonstrated the existence of tetramers with 4-fold
symmetry and higher order oligomers that are multiples of
tetramers. This is similar to our observation of 4-fold symmetry for
the tetramer in the present crystal structure. Thirdly, earlier
analytical centrifugation, dynamic laser light scattering and our
glutaraldehyde cross-linking experiments (Figure S1) confirm the
presence of the tetramer and other oligomers of Nef. The
individual core-domains in the crystals are well defined in the
electron density maps (Figure 2A) except for the 30-residue loop
that was disordered in the earlier core domain complexes also.
The domain adopts an a/b fold and contains 4 antiparallel b-
Figure 1. Sequence alignment of the present full-length HIV-1 Nef (NefRP14) with NL4-3. NL4-3 and RP14 sequences are shown in green
and black color respectively. The main differences between the sequences involve the insertion of 9 residues after Arg20 and the deletion of the
CAWLEAQ motif containing residues 55-61 in the NL4-3 sequence. The conserved Asp123 of the earlier NL4-3 sequence corresponds to Asp125 in the
present structure. The XR motif involving residues 105–106 in the earlier NL4-3 sequence corresponds to residues 107–108 in the present structure.
The PXXP motif in the present structure is from residues 74–80 while the 30-residue disordered loop distal to this motif ranges from residues 151–
180.
doi:10.1371/journal.pone.0026629.g001
Crystal Structure of Tetrameric HIV-1 Nef
PLoS ONE | www.plosone.org 2 November 2011 | Volume 6 | Issue 11 | e26629strands straddled primarily by two long and two short a-helices
respectively (Figure 2B, C). Details of the tertiary structure of the
domain have been described by earlier workers [9,10] and will not
be mentioned here. They exhibit r.m.s.d values ranging between
0.69 and 0.83 A ˚ between themselves and earlier reported
structures of the domain. These values are not indicative of
substantial changes to the tertiary structure as they are in the range
of the average co-ordinate errors of the respective compared
structures. On the other hand, the N-terminal anchor domain is
disordered in the full-length structure. The presence of the full-
length protein in the crystals was however confirmed by crushing a
couple of crystals after washing them and running an SDS PAGE
gel (Figure S2). Additionally, the crystal packing was consistent
with the presence of the full-length protein. The disordered nature
of the anchor domain is not surprising; as in earlier NMR studies
the N-terminal domain is loosely structured and does not have a
well-defined fold [18]. Additionally, in the Nefcore—FynSH3
complex, the crystallized Nef deletion-construct consisted of
residues 54–205 but the first 16 residues were disordered [9].
HIV-1 Nef exhibits unprecedented dimer-tetramer
transition
The protein exists as a tetramer in the crystals. Surprisingly, the
tetramer exhibits 4-fold symmetry as opposed to a normally
expected 222 symmetry [23,24] when two dimers associate
together (Figure 2C). The observed tetrameric association is in
agreement with earlier reported solution studies and small-angle
X-ray scattering experiments where a tetramer and hexadecamer
with 4-fold symmetry were observed [12]. In line with the earlier
reports, our glutaraldehyde cross-linking experiments (Figure. S1)
Figure 2. The crystal structure of HIV-1 Nef (NefRP14). (A) A section of the 2Fo-Fc electron density map (violet mesh) contoured at 1s around
R108 and D125. (B) Labeled stick representation of the two chains in the asymmetric unit. (C) Tetrameric association of full-length HIV-1 Nef.
Individual chains are distinctly colored and shown in cartoon representation. The PXXP motif (residues 74–80) of each chain is marked in red. The a-
helices of one chain are labeled for clarity. The location of protein interaction motifs in the 151–180 disordered loop is schematically indicated. (D)
The full-length HIV-1 Nef forms a tetramer with a 4-fold symmetry (bottom right). This is unexpected because normally a dimer to tetramer transition
involves an association that exhibits 222 symmetry as schematically illustrated in the figure. The dimer to tetramer transition in Nef involves large
changes to the relative spatial disposition of the subunits of the dimer. The Nefcore dimeric association is shown on the left. The observed symmetry in
the Nef tetramer crystal structure is supported by earlier small angle solution X-ray scattering experiments where tetramers and higher order
oligomers with 4-fold symmetry were observed.
doi:10.1371/journal.pone.0026629.g002
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similar to the results of the other earlier experiments involving Nef.
As per well established principles of protein oligomerization
[23,24], the tetrameric association of proteins composed of
identical subunits can correspond to either C4 symmetry where
the four subunits are related by a 4-fold rotation or alternatively by
222 symmetry that occurs when two dimers associate as a ‘dimer
of dimers’. Deviations from these principles are rare and when
present are functionally justified. The formation of the Nef
tetramer involves unexpected large changes to the intersubunit
disposition of the core-domains in the earlier dimer to form a
tetramer with C4 symmetry (Figure 2D). Compared to the dimeric
association of the earlier ‘open’ form, one subunit of the core-
domain swings out with a relative rotation of about 174u and
translation by ,22 A ˚ with respect to the respective center of
masses (Figure 3A; bottom panel). Further association with
another symmetric pair leads to the formation of the tetramer.
This leads to the steric shielding of the PXXP motif in the
tetramer. The functional implications of the changes that occur
upon formation of the tetramer are discussed later.
The conserved Asp125 interaction with the XR motif that
is important for viral replication is retained in closed and
open forms
The interactions in a dimeric interface are normally symmet-
rical keeping in view the two-fold symmetry of the protein-protein
interaction interface. Accordingly in the Nefcore—FynSH3 domain
complex the main polar interactions occur between Asp123 and
Arg105 (numbering in their construct, See Figure 1) and the
reverse symmetric interactions. The Arg105 of the earlier Nefcore
structure is the first residue of the conserved XR motif, where X is
either R or K [19,20]. In the tetrameric association the Asp125
(Asp123 of Nefcore structure) now interacts with the second R
residue of the XR motif (Figure 3A; upper panel). A list of the
interactions in the respective intersubunit interfaces of the ‘open’
and the present ‘closed’ forms is in Table 1. Earlier in vivo studies
involving mutations to the Asp residue demonstrated that it leads
to the severe deficiency to oligomerization and consequently to
viral replication [25,22]. Similarly, mutations to the XR motif also
lead to severe functional consequences [22]. Very recent in vivo and
solution studies [26] support different oligomerization modes in
Nef but did identify that the XR motif and Asp125 play important
roles. The present structure underscores the importance of the
interaction of these two motifs in Nef oligomerization. It shows
how the protein apparently can switch from a dimeric to a
tetrameric association by minor changes to the intersubunit
interactions. It is worth emphasizing in this context that both the
residues of the XR motif are within ‘striking’ distance of the
conserved Asp in both the oligomeric forms.
HIV-1 Nef modulates its distinct functions through novel
changes to oligomerization
Superposition of the Nefcore—FynSH3 complex onto the
tetramer shows that the binding of SH3 domains to the tetramer
Figure 3. Dimer-tetramer oligomeric changes and occlusion of PXXP motif in HIV-1 Nef (NefRP14). (A)( Bottom panel) Changes to the
relative spatial disposition of the two chains of the Nefcore dimer (lavender) from the earlier ‘open’ structures to that observed in the present full-
length tetramer (individual chains depicted in cyan). One subunit from the respective associations is superposed and the relative spatial changes to
the other subunit are shown. The ‘moving’ subunit is rotated by ,174u while the center of mass is translated by ,22.7 A ˚. Despite the large changes
that result in the formation of the tetramer, the interactions of Asp125 with residues of the XR motif (residues 107–108) (shown as a close-up in the
upper panel) is retained. (b) One chain along with the SH3 domain (surface representation) from the Nefcore-FynSH3 complex superposed onto the
tetrameric association of the full-length HIV-1Nef (cartoon representation). The SH3 domains exhibit severe steric clashes precluding their interactions
with the tetrameric form of Nef. The PXXP motif (shown as spheres) cannot interact with the domain in the tetramer while the motifs present on the
labeled 151–180 residue loop are exposed and can interact with other subsets of interacting protein partners.
doi:10.1371/journal.pone.0026629.g003
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leads to severe steric conflicts (Figure 3B). The PXXP recognition
motif is therefore not accessible to the SH3 domains of partner
proteins in the tetramer. However accessible surface area
calculations show that the accessibility of the hydrophobic pocket
between the aA and aB helices is not affected when going from the
‘open’ to ‘closed’ forms. Conceptually, this will allow for the
proposed sequestering of the myristoylated N-terminal segment in
the hydrophobic pocket when the protein is not vicinal to
membranes [12]. It is also available for its suggested role in fine-
tuning interactions with other protein partners as observed in the
Nefcore—FynSH3 complexes. The 30-residue loop located distal to
the PXXP motif, mentioned earlier, contains several motifs for
interactions with other protein partners. An examination of the
tetrameric association shows that this loop is available for
interactions with protein partners (Figure 2C & 3B). An oblique
support for this hypothesis is from the very recent crystal structures
of the Nef –core domain, allele SF2 complexed to the SH3 domain
of human Hck kinase [27]. In this latter complex the 30-residue
loop is ordered and stabilized by crystal contacts with the
conserved hydrophobic groove of a neighboring Nef molecule. It
however does not interact with the SH3 domain of the kinase
supporting distinct roles for the PXXP motif and the other protein
interaction motifs located on the 30-residue loop. Thus the Nef
tetramer can selectively abrogate the recognition of SH3 domains
while allowing for interactions with other subsets of its repertoire
of protein partners. This offers an elegant molecular mechanism
for the modulation of at least a subset of the functions enforced by
HIV-1 Nef in the cell. Roles of these and other postulated
quaternary associations in the overall Nef functions and ‘cycle’
needs additional concerted work. However, the implications of the
present are results are discussed below.
Nef oligomers and their importance in the overall ‘Nef-
cycle’
It is perplexing as to how Nef mediates the interactions with a
large number of proteins, especially given its rather small size and
how it results in diverse functional consequences. It is generally
agreed that conformational changes based on the cellular location
of Nef plays an important role. Interaction motifs are distributed in
the protein in primarily two regions; the first involves the PXXP
motif and the other involves motifs situated in the 30-residue loop.
The oligomeric changes exhibited by Nef were associated with the
enforcing of the multiple distinct functions of the protein [8,18]. It
is also known that Nef exists as smaller oligomers in the vicinity of
membranes where it interacts with a distinct set of proteins while it
interacts with other proteins in the cytoplasm [8,18]. The
myristoylated N-terminus that interacts with membranes has to
be sequestered in the cytoplasmic stage. The earlier Nefcore—
FynSH3 complex, where the association is dimeric, gave a detailed
picture, perhaps reminiscent of the interactions of Nef in the
vicinity of membranes. Other groups have reported detailed
solution studies involving the cytoplasmic form of Nef including
solution X-ray scattering, analytical ultracentrifugation and
dynamic laser light scattering [12]. These studies have revealed
that Nef exists as a tetramer with 4-fold symmetry and also that it
forms a hexadecamer when 4 such tetramers associate together.
These earlier studies supported that large changes should take
place in the Nef oligomeric association when going from the
membrane-associated ‘open’ form to the cytoplasmic ‘closed’
form. The relationship between this higher oligomeric form and
function however remained unclear. The present work affords
definitive insights as to how the oligomeric changes in Nef enable it
to distinguish between subsets of its multiple interacting partners.
The shielding of the PXXP motif of Nef in the cytoplasmic stage
prevents the binding of SH3 domains of selected proteins that
presumably interact with it in the lower order membrane-
associated form. It however allows for Nef to interact with other
selected partners in the cytoplasmic stage since the 151–180 loop
containing other interaction motifs is accessible. The structure also
affords insights as to how the myristoylated N-terminus of Nef that
is membrane-associated in the ‘open’ form, and also binds to the
core domain of Nef [13], can be occluded in the cytoplasmic stage
since the earlier suggested [12] binding pocket between helices aA
and aB (Figure 2C) remains accessible in the tetramer. Consistent
with these suggestions a recent report involving [27] the NefSF2 –
HckSH3-B6 complex and associated Isothermal calorimetry studies
showed that myristoylation of Nef does not interfere with the SH3
domain binding activity. It also showed that the 151–180 loop
does not interact with the predicted binding site of myristoylated
peptides in the hydrophobic groove between helices aA and aB.
Future complexes of Nef with proteins that interact with motifs in
the 151–180 loop should reveal molecular details of interactions
with the latter. These complexes do not preclude additional
Table 1. Polar interactions less than 4 A ˚ between the subunits in the full-length Nef tetramer.
(A) Interactions in the tetramer (Full-length Nef)
Subunit 1 Subunit 2 Distance (A ˚)
Asp125-OD2 Arg108-NH2 3.1
Arg108-NE 3.2
Leu78-O Gly98-O 3.3
(B) Interactions in the Nefcore dimer
Subunit 1 Subunit 2 Distance (A ˚)
Asp123-OD2 Arg105-NH2 3.3
Arg105-NE 3.8
Arg105-NH1 Asp123-OD2 2.5
Asp123-OD1 4.0
The interactions in the Nefcore dimer is also tabulated separately for ready comparison. The residue numbering follows the respective structures. An additional polar
interaction in the Nef tetramer compared to the Nefcore dimer involves Leu78 and Gly98 respectively.
doi:10.1371/journal.pone.0026629.t001
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interactions with the target proteins. A support for this proposal
comes from very recent structural studies involving the core
domain of SIVmac239 isolate of Nef (SIVmac239 Nefcore) with
two interacting peptides derived from the signalling f subunit of
the T-cell receptor (TCRf) [28]. In these latter studies a relative
10u rotation between the respective core domains was observed
when comparing the two complexes. Multiple modes of oligo-
merization in the SIV ortholog of Nef were also shown recently
through solution and cell based studies [26]. In these studies
alternate models of dimer formation in SIV-Nef was suggested.
The authors further reported that the di-basic XR motif is
important for these alternate modes of oligomerization also. The
present work involving the HIV-1 Nef represents novel insights to
aspects of the large quaternary structural and other changes that
are apparently exploited by Nef to enforce its functions.
Conclusions
Overall, the present work shows that there is nothing ‘closed’
about the structure of the cytoplasmic form of Nef and that the
protein controls interactions with different partners in novel ways.
The shielding of the PXXP motif that interacts with the SH3
domains in the tetramer is unanticipated. We know of no other
example where a dimer breaks its 2-fold symmetry to form a 4-fold
symmetric tetramer. The unprecedented changes however retain
the key interactions of Asp125 with the XR motif that were earlier
shown to be essential for viral replication [22]. Furthermore the
importance of the Asp125- XR motif interactions in oligomeric
assembly is underscored by the present work. The nature of the
bond (salt-bridge) apparently allows for the subunits to be
associated with each other while undergoing the large relative
displacements when going from the dimeric to tetrameric forms.
Given the highly conserved and essential nature of the Asp125-
XR interactions it remains to be seen whether these can be
disrupted as an innovative route to the development of novel anti
HIV therapeutics.
Materials and Methods
Ethics statement
The study was approved by the Human Ethical Committee of
the ‘Chhatrapati Shahuji Maharaj Medical University (old name:
King George Medical University), Lucknow-226003 (UP) India,
with Ref. Code: XVIII ECM/P9. The written informed consent
was obtained from all study participants.
Genomic DNA isolation, PCR amplification and
sequencing of HIV-1 Nef gene
Peripheral Blood Mononuclear Cells (PBMCs) were isolated
from a random HIV-1 infected individual, after informed consent,
using the standard Ficoll density gradient centrifugation method
(Sigma). The study was approved by the Human Ethical
Committee of the ‘Chhatrapati Shahuji Maharaj Medical
University’ (old name: King George Medical University), Luck-
now-226003 (UP) India, with Ref. Code: XVIII ECM/P9. The
written informed consent was obtained from all study participants.
Genomic DNA was isolated from fresh PBMCs by a genomic
extraction kit (Invitrogen). Nested PCR approach [29] was used to
amplify the Nef gene using different sets of primers, outer forward
primers POLU 59-CCCTAYAACCMCARAGYCARGG-39 and
outer reverse LTRR 59-GACTACGGCCGTCTGAGG-
GATCTCTAGYTACCA-39 and Inner forward Primer NOFP
59-ATACCTASAMGAATMAGACACARGG-39 and inner re-
verse primer NORP 59-CTGCTTATATGCAGCATCT-
GAGGG-39) [30]. The amplified PCR fragments were cloned
into the pDrive T/A cloning vector (Invitrogen). Three clones per
sample were sequenced using M13 forward and reverse sequenc-
ing primers using the Bigdye terminator chemistry on an
automated sequencer (ABI prism 310 genetic analyzer, Applied
Biosystems). The sequences obtained were assembled using the
AutoAssembler (ABI PRISM) DNA sequence assembly software
(Figure 1). The sequence of the NefRP14 gene was submitted to
the GenBank with the accession number: GQ184340.
Cloning, Over-expression and Purification of His-tagged
HIV-1 Nef
The Nef gene was amplified and cloned into the TA cloning
vector (Invitrogen) using forward primer P14BF 59-CATG-
GATCCCAGCAGCAGAAAGGAGA-39 and reverse primer
NX1R CCAGGTCTAGACCCAGCGGAAAGTCCC-39 with
BamHI restriction sites at their overhangs and subsequently
subcloned into the pET28a bacterial expression vector (Novagen).
The pET-28a-Nef plasmid containing hexahistidine tags was
transformed into the C41 bacterial strain. The single colony
culture was induced by the addition of 0.8 mM IPTG at 37uC for
6 hrs. Before purification the expression and solubility was
checked on SDS-PAGE. The protein was purified by affinity
chromatography using a Ni-NTA column and Tris-Cl (25 mM
pH 8.8), NaCl (50 mM) buffer. The protein eluted at 350 mM
imidazole concentration and was subjected to 12% SDS PAGE
analysis where the Page Ruler
TM Prestained Protein Ladder
(Fermentas Cat. SM0671) was used as a molecular weight marker
(Figure S2). Subsequently gel filtration experiments were carried
out using a Superdex-200 HR 10/30 column mounted on an
AKTA FPLC (GE Healthcare). The column was equilibrated with
50 mM Tris-HCl (pH 8.5), 100 mM NaCl, 5 mM EDTA and
2 mM 2-mercaptoethanol. The purified protein was concentrated
using a 10 kDa cutoff centricon (Ms/Amicon) for further use.
Glutaraldehyde cross-linking
The purified Nef protein was incubated with increasing
concentrations of Glutaraldehyde (0.0%, 0.025%, 0.05%,
0.075% and 0.1%) on ice for 15 minutes. Respective samples
were prepared and run on 12% SDS-PAGE. The gel was
visualized after silver staining it. The gel was subjected to western
blotting using anti-His antibody to unambiguously identify the
oligomeric bands (Figure S1).
Crystallization, data collection and processing
Crystallization trials using the hanging drop method (2:1 ratio of
protein and precipitant solutions) were carried out using the
purified Nef at a concentration of ,3.7 mg/ml. Various
constructs based on the Nef variants from patient samples were
used for crystallization trials and ultimately we were successful
with one such construct for reasons outlined in ‘Results’. The
crystals of Nef (GenBank accession number: GQ184340) was
obtained in the condition with 0.1 M Tris (pH 8.5), 0.2 M
Ammonium sulfate, 20% PEG 8000. The full length HIV-1 Nef
formed hexagonal shaped crystals. The presence of the full-length
protein in the crystals was confirmed by crushing a couple of
crystals after washing them and running an SDS PAGE gel.
Crystal diffraction and poor reproducibility were problems faced
during the experiments and in hindsight were probably due to the
disordered N-terminal domain as explained in ‘Results’. The
crystals were flash frozen after briefly soaking them in the
precipitant solution supplemented with 30% glycerol for data
collection. A Rigaku Micromax 007HF X-ray generator was
Crystal Structure of Tetrameric HIV-1 Nef
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and used in the data collection. An Oxford Cryostream700
instrument was used to maintain the temperature at 100uK. Most
of the crystals diffract rather weakly and therefore many crystals
were screened before the data collection. The crystals belong to
space group P6322 (a=b=123.03; c=130.4 A ˚) and diffract to
3.5 A ˚. The data collection and refinement statistics are summa-
rized in Table 2. Data integration, reduction and scaling were
performed using MOSFLM [31] and its companion program
SCALA [32]. Data were overall complete to 94.8% with an
average redundancy of 5.7. Crystal mosaicity values refined to
0.67. The Matthews’s coefficient of 2.37 A ˚ 3/Da or solvent content
of about 48.7% suggested that 2 molecules were there in the
asymmetric unit.
Structure solution, refinement, model building and
validation
The structure was solved using molecular replacement (MR)
techniques employing the program Phaser [33]. Since models are
available only of the C- and N-terminal domains of the protein
respectively, we followed a strategy of independently searching
for the two domains. Three structures of the core domain were
superposed using PROFIT (http://www.bioinf.org.uk/software/
profit) and parts of 1AVV, which structurally align well, were
identified visually. Non-conserved residues were converted to
alanine in the search model. Data in the resolution range 29.6-
3.5 A ˚ were used for molecular replacement calculation. Calcu-
lations were carried out in all the sub-groups of P622. The correct
solution was in the space group P6322 and the packing was
examined carefully. There are two independent chains in the
asymmetric unit. There was also enough space to accommodate
the N-terminal domain that was yet to be placed. Calculations
involving the available myristoylated and non-myristoylated
structures of the N-terminal domain were not successful despite
various parameters like the resolution range etc being changed.
An examination of the electron density maps at this stage
suggested that the N-terminal domains might be disordered as
suggested by weak trailing density at the start of the C-terminal
core domain. The core domain itself was well defined in the
electron density maps. We therefore started model building with
a view that improved phases after model building might result in
better maps for modeling the N-terminal domain. Ultimately we
realized that the N-terminal domain is disordered, although it is
present in the crystals (Figure S2). A long loop of the core domain
from 151–180 is also disordered in the crystal structure. This is
disordered in the earlier reported structures of the core-domain
also. Refinements were carried out using REFMAC5 [34] in the
initial stages while model building was carried out using
TURBO-FRODO [35] and COOT. In the later stages we took
recourse to the PHENIX package [36] for the refinements. The
starting models derived from the molecular replacement calcu-
lations were subjected to rigid body refinement with the
respective subunits treated as rigid units. An independent set
consisting of 5% of the diffraction data were set aside to monitor
the R-free value during the course of refinements. NCS
constraints were imposed till the penultimate cycles of refinement.
The crystallographic R-factor and R-free [37] were monitored at
each stage and omit maps were checked to avoid model bias.
These values stand at 22.46 and 28.8% respectively in the final
model. It is possible that the disorder of the large N-terminal
domain could have contributed to relatively weaker diffraction of
the crystals. PROCHECK was used to assess the quality of the
model after every round of refinement.
Accession numbers
The coordinates and structure factors have been deposited in
the Protein Data Bank (http://www.rcsb.org) with accession codes
2XI1 and R2XI1SF respectively.
Supporting Information
Figure S1 Glutaraldehyde crosslinking experiments
with HIV-1Nef. (A)The Nef protein was crosslinked by
glutaraldehyde with 0.0% (control), 0.025%, 0.05%, 0.075%,
0.1% concentrations respectively and subsequently run on 12%
SDS-PAGE. The gel was silver stained to visualize the different
oligomeric forms of Nef protein. (B) Since the purified protein
contains a hexa-His tag, we unambiguously identified the
oligomeric forms by western blotting with anti-His antibody.
(PDF)
Figure S2 SDS-PAGE gel of crushed HIV-1 Nef crystals
(right) run along with the molecular weight marker from
Fermentas. A sample gel from a purification run is shown on the
left for comparison. Lane L5 corresponds to the purified eluted
protein from the Ni-NTA column while lanes L1-L4 correspond to
the other stages of purification including the wash cycles.
(PDF)
Table 2. Data collection and refinement statistics for full
length HIV-1 Nef.
HIV-1 Nef
Data collection
Space group P6322
Cell dimensions
a, b, c (A ˚) 123.03, 123.03, 130.4
a,b,c (u) 90.0, 90.0, 120.0
Resolution (A ˚) 3.5 (3.72-3.5)*
Rmerge 0.12(0.67)
I/sI 7.1(3.9)
Completeness (%) 94.8(89.6)
Redundancy 5.7(4.5)
Refinement
Resolution (A ˚) 29.6-3.5
No. reflections 7262
Rwork/Rfree 22.46/28.80
No. atoms
Protein 1686
Ligand/ion -
Water 49
B-factors
Protein 37
Ligand/ion -
Water 30
R.m.s. deviations
Bond lengths (A ˚) 0.01
Bond angles (u)1 . 4
Data were collected using 1 flash frozen crystal at 100uK.
*Values in parentheses are for highest-resolution shell.
doi:10.1371/journal.pone.0026629.t002
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